tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Terence Flynn, 125 are a HOLD (39.18%), 35 are a SELL (10.97%), 159 are a BUY (49.84%).
Analyst Terence Flynn, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 65.29% that have a potential upside of 22.05% achieved within 232 days.
Terence Flynn’s has documented 658 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRSP, Crispr Therapeutics AG at 18-Feb-2025.
Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for ARVN (ARVINAS) at 11/13/2023. The price target of $20 was fulfilled within 2 days with a profit of $3.41 (20.55%) receiving and performance score of 102.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$32
$-3.32 (-9.40%)
$30
8 days ago
(14-Feb-2025)
12/18 (66.67%)
$-3.89 (-10.84%)
680
Hold
$46
$10.68 (30.24%)
$37
9 days ago
(13-Feb-2025)
19/23 (82.61%)
$10 (27.78%)
295
Buy
$40
$4.68 (13.25%)
$35
3 months 9 days ago
(13-Nov-2024)
4/6 (66.67%)
$10.76 (36.80%)
699
Buy
$36
$0.68 (1.93%)
$25
3 months 17 days ago
(05-Nov-2024)
20/27 (74.07%)
$7.63 (26.89%)
141
Buy
$43
$7.68 (21.74%)
$48
3 months 28 days ago
(25-Oct-2024)
0/5 (0%)
$16.91 (64.81%)
Which stock is Terence Flynn is most bullish on?
Which stock is Terence Flynn is most reserved on?
What Year was the first public recommendation made by Terence Flynn?
